# Chapter 6: ì˜ë£Œ ì˜¨í†¨ë¡œì§€

**í•™ìŠµ ì‹œê°„:** 90ë¶„  
**ë‚œì´ë„:** â­â­â­â­  
**ì‹œë®¬ë ˆì´í„°:** 3D Knowledge Graph â­  
**ì‘ì„±ì¼:** 2025-11-09  
**ë²„ì „:** 3.0 FINAL

---

## ğŸ¯ í•™ìŠµ ëª©í‘œ

ì´ ì±•í„°ë¥¼ ë§ˆì¹˜ë©´ ë‹¤ìŒì„ í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤:

1. âœ… SNOMED CTì˜ êµ¬ì¡°ì™€ 350,000+ ê°œë… ì²´ê³„ë¥¼ ì´í•´í•œë‹¤
2. âœ… FHIR ë¦¬ì†ŒìŠ¤ì™€ ì˜¨í†¨ë¡œì§€ì˜ ì—°ê³„ë¥¼ ì„¤ëª…í•œë‹¤
3. âœ… Disease Ontology, Gene Ontology, DrugBankë¥¼ í™œìš©í•œë‹¤
4. âœ… ì‹¤ì œ ë³‘ì› ì‚¬ë¡€ (Mayo Clinic, Cleveland Clinic)ë¥¼ ë¶„ì„í•œë‹¤
5. âœ… ì˜ë£Œ AI + ì˜¨í†¨ë¡œì§€ í†µí•©ì„ ì´í•´í•œë‹¤
6. âœ… ì§ˆë³‘-ìœ ì „ì-ì•½ë¬¼ ê´€ê³„ë¥¼ 3Dë¡œ ì‹œê°í™”í•œë‹¤
7. âœ… ì •ë°€ ì˜ë£Œ(Precision Medicine)ì—ì„œì˜ ì˜¨í†¨ë¡œì§€ ì—­í• ì„ íŒŒì•…í•œë‹¤

---

## ğŸ“š ëª©ì°¨

1. [ì˜ë£Œ ì˜¨í†¨ë¡œì§€ë€?](#1-ì˜ë£Œ-ì˜¨í†¨ë¡œì§€ë€)
2. [SNOMED CT ì™„ì „ ê°€ì´ë“œ](#2-snomed-ct-ì™„ì „-ê°€ì´ë“œ)
3. [FHIRì™€ ì˜¨í†¨ë¡œì§€](#3-fhirì™€-ì˜¨í†¨ë¡œì§€)
4. [Disease Ontology](#4-disease-ontology)
5. [Gene Ontology](#5-gene-ontology)
6. [DrugBank](#6-drugbank)
7. [ì‹¤ì œ ë³‘ì› ì‚¬ë¡€](#7-ì‹¤ì œ-ë³‘ì›-ì‚¬ë¡€)
8. [ì˜ë£Œ AI + ì˜¨í†¨ë¡œì§€](#8-ì˜ë£Œ-ai--ì˜¨í†¨ë¡œì§€)
9. [ì •ë°€ ì˜ë£Œ](#9-ì •ë°€-ì˜ë£Œ)
10. [ì‹¤ìŠµ: ì§ˆë³‘-ìœ ì „ì-ì•½ë¬¼ ê·¸ë˜í”„](#10-ì‹¤ìŠµ-ì§ˆë³‘-ìœ ì „ì-ì•½ë¬¼-ê·¸ë˜í”„)
11. [FDA ì‹ ì•½ ìŠ¹ì¸ ê³¼ì •](#11-fda-ì‹ ì•½-ìŠ¹ì¸-ê³¼ì •)
12. [ì„ìƒ ì˜ì‚¬ê²°ì • ì§€ì›](#12-ì„ìƒ-ì˜ì‚¬ê²°ì •-ì§€ì›)
13. [ìš”ì•½ê³¼ ë‹¤ìŒ ë‹¨ê³„](#13-ìš”ì•½ê³¼-ë‹¤ìŒ-ë‹¨ê³„)

---

## 1. ì˜ë£Œ ì˜¨í†¨ë¡œì§€ë€?

### ì˜ë£Œ ì˜¨í†¨ë¡œì§€ì˜ ì •ì˜

**ì˜ë£Œ ì˜¨í†¨ë¡œì§€**ëŠ” ì˜ë£Œ ì§€ì‹ì„ ì²´ê³„ì ìœ¼ë¡œ í‘œí˜„í•˜ê³  ê³µìœ í•˜ê¸° ìœ„í•œ í‘œì¤€í™”ëœ ì–´íœ˜ì™€ ê´€ê³„ì˜ ì§‘í•©ì…ë‹ˆë‹¤.

### ì™œ ì˜ë£Œì—ì„œ ì˜¨í†¨ë¡œì§€ê°€ ì¤‘ìš”í•œê°€?

**1. ìš©ì–´ì˜ í‘œì¤€í™”**
```
ê°™ì€ ë³‘:
- ë³‘ì› A: "Type 2 Diabetes"
- ë³‘ì› B: "T2DM"
- ë³‘ì› C: "ë‹¹ë‡¨ë³‘"
- ë³‘ì› D: "ì œ2í˜• ë‹¹ë‡¨"

â†’ SNOMED CT: 44054006
```

**2. ìƒí˜¸ìš´ìš©ì„± (Interoperability)**
- ì„œìš¸ëŒ€ë³‘ì› â†’ ì‚¼ì„±ë³‘ì› í™˜ì ì´ì†¡
- ì „ìê±´ê°•ê¸°ë¡(EHR) êµí™˜
- êµ­ê°€ ê°„ ì˜ë£Œ ë°ì´í„° ê³µìœ 

**3. ì„ìƒ ì˜ì‚¬ê²°ì • ì§€ì›**
```
ì§ˆë¬¸: "ì´ ì•½ê³¼ ìƒí˜¸ì‘ìš©í•˜ëŠ” ì•½ì€?"
ì˜¨í†¨ë¡œì§€:
ì•½ë¬¼A â†’ ìƒí˜¸ì‘ìš© â†’ ì•½ë¬¼B
     â†’ ê¸ˆê¸°ì¦ â†’ ì§ˆí™˜C
```

**4. ì—°êµ¬ì™€ ë¶„ì„**
- ëŒ€ê·œëª¨ ì„ìƒ ì—°êµ¬
- ì§ˆë³‘ íŒ¨í„´ ë¶„ì„
- ì‹ ì•½ ê°œë°œ

### ì£¼ìš” ì˜ë£Œ ì˜¨í†¨ë¡œì§€ 8ê°œ

| ì˜¨í†¨ë¡œì§€ | ë²”ìœ„ | ê°œë… ìˆ˜ | ê´€ë¦¬ ê¸°ê´€ |
|----------|------|---------|-----------|
| **SNOMED CT** | ì„ìƒ ìš©ì–´ ì „ì²´ | 350,000+ | IHTSDO |
| **ICD-10/11** | ì§ˆë³‘ ë¶„ë¥˜ | 70,000+ | WHO |
| **LOINC** | ê²€ì‚¬ ê²°ê³¼ | 94,000+ | Regenstrief |
| **RxNorm** | ì˜ì•½í’ˆ | 130,000+ | NLM |
| **Disease Ontology** | ì§ˆë³‘ | 10,000+ | Open Community |
| **Gene Ontology** | ìœ ì „ì ê¸°ëŠ¥ | 44,000+ | GOC |
| **DrugBank** | ì•½ë¬¼ ìƒí˜¸ì‘ìš© | 14,000+ | University of Alberta |
| **FHIR** | ë¦¬ì†ŒìŠ¤ êµí™˜ | - | HL7 |

---

## 2. SNOMED CT ì™„ì „ ê°€ì´ë“œ

### SNOMED CTë€?

**SNOMED CT (Systematized Nomenclature of Medicine - Clinical Terms)**ëŠ” ì„¸ê³„ì—ì„œ ê°€ì¥ í¬ê´„ì ì¸ ì„ìƒ ì˜ë£Œ ìš©ì–´ ì²´ê³„ì…ë‹ˆë‹¤.

**ê°œë°œ:** IHTSDO (International Health Terminology Standards Development Organisation)  
**ê°œë… ìˆ˜:** 350,000+  
**ê´€ê³„ ìˆ˜:** 1,500,000+  
**ì–¸ì–´:** ì˜ì–´, ìŠ¤í˜ì¸ì–´, ì¤‘êµ­ì–´ ë“±

### SNOMED CT êµ¬ì¡°

**5ê°€ì§€ í•µì‹¬ ìš”ì†Œ:**

**1. Concepts (ê°œë…)**
- ê³ ìœ  ID (SNOMED CT Identifier)
- ì˜ˆ: 44054006 = "Type 2 diabetes mellitus"

**2. Descriptions (ì„¤ëª…)**
- FSN (Fully Specified Name): ì™„ì „í•œ ì´ë¦„
- Preferred Term: ì„ í˜¸ ìš©ì–´
- Synonyms: ë™ì˜ì–´

**3. Relationships (ê´€ê³„)**
- IS-A: ê³„ì¸µ ê´€ê³„
- Finding site: ë°œê²¬ ë¶€ìœ„
- Causative agent: ì›ì¸ ë¬¼ì§ˆ

**4. Reference Sets**
- íŠ¹ì • ëª©ì ì˜ ê°œë… ì§‘í•©
- ì˜ˆ: ì‘ê¸‰ì‹¤ ì½”ë“œ ì„¸íŠ¸

**5. History**
- ë²„ì „ ê´€ë¦¬
- ë³€ê²½ ì´ë ¥

### SNOMED CT ê³„ì¸µ êµ¬ì¡°

```
Clinical finding (404684003)
â”œâ”€ Disease (64572001)
â”‚  â”œâ”€ Disorder of endocrine system (362969004)
â”‚  â”‚  â”œâ”€ Diabetes mellitus (73211009)
â”‚  â”‚  â”‚  â”œâ”€ Type 1 diabetes (46635009)
â”‚  â”‚  â”‚  â”œâ”€ Type 2 diabetes (44054006) â­
â”‚  â”‚  â”‚  â””â”€ Gestational diabetes (11687002)
â”‚  â”‚  â””â”€ Thyroid disorder (14304000)
â”‚  â””â”€ Cardiovascular disease (49601007)
â””â”€ Symptom (418799008)
```

### SNOMED CT ê´€ê³„ ìœ í˜•

**ì£¼ìš” ê´€ê³„ 8ê°€ì§€:**

**1. IS-A (ê³„ì¸µ)**
```turtle
:Type2Diabetes rdfs:subClassOf :DiabetesMellitus .
:DiabetesMellitus rdfs:subClassOf :EndocrineDisorder .
```

**2. Finding Site (ë°œê²¬ ë¶€ìœ„)**
```turtle
:Pneumonia :findingSite :Lung .
```

**3. Causative Agent (ì›ì¸)**
```turtle
:BacterialPneumonia :causativeAgent :Bacteria .
```

**4. Associated Morphology (ë³‘ë¦¬ í˜•íƒœ)**
```turtle
:Inflammation :associatedMorphology :Swelling .
```

**5. Procedure Site (ì‹œìˆ  ë¶€ìœ„)**
```turtle
:Appendectomy :procedureSite :Appendix .
```

**6. Has Ingredient (ì„±ë¶„)**
```turtle
:Aspirin :hasActiveIngredient :AcetylsalicylicAcid .
```

**7. Has Dose Form (íˆ¬ì—¬ í˜•íƒœ)**
```turtle
:AspirinTablet :hasDoseForm :Tablet .
```

**8. Occurs After (ìˆœì„œ)**
```turtle
:PostOperativeInfection :occursAfter :Surgery .
```

### SNOMED CT RDF ì˜ˆì œ

```turtle
@prefix snomed: <http://snomed.info/id/> .
@prefix sct: <http://snomed.info/sct/> .

# Type 2 Diabetes
snomed:44054006 a owl:Class ;
    rdfs:label "Type 2 diabetes mellitus"@en ;
    rdfs:label "ì œ2í˜• ë‹¹ë‡¨ë³‘"@ko ;
    sct:116680003 snomed:73211009 ;  # IS-A Diabetes mellitus
    sct:363698007 snomed:113331007 ; # Finding site: Endocrine system
    sct:246454002 snomed:7087005 .   # Associated with: Insulin resistance

# ì¶”ë¡  ê°€ëŠ¥:
# Type 2 Diabetes IS-A Diabetes IS-A Endocrine Disorder
```

### SNOMED CT ì‚¬ìš© ì‚¬ë¡€

**ì‚¬ë¡€ 1: ì „ìê±´ê°•ê¸°ë¡ (EHR)**

**ë¬¸ì œ:**
```
ì˜ì‚¬ A: "í™˜ìê°€ T2DMì´ ìˆìŠµë‹ˆë‹¤"
ì˜ì‚¬ B: "ì œ2í˜• ë‹¹ë‡¨ë³‘"ìœ¼ë¡œ ê²€ìƒ‰
â†’ ëª» ì°¾ìŒ!
```

**SNOMED CT í•´ê²°:**
```turtle
# ëª¨ë“  ìš©ì–´ê°€ 44054006ìœ¼ë¡œ ë§¤í•‘
"T2DM" â†’ 44054006
"Type 2 Diabetes" â†’ 44054006
"ì œ2í˜• ë‹¹ë‡¨ë³‘" â†’ 44054006
"Non-insulin-dependent diabetes" â†’ 44054006

# ê²€ìƒ‰ ê²°ê³¼ í†µí•© âœ…
```

**ì‚¬ë¡€ 2: ì•½ë¬¼ ìƒí˜¸ì‘ìš©**

```sparql
# "Type 2 Diabetes í™˜ìì—ê²Œ ê¸ˆê¸°ì¸ ì•½ë¬¼ì€?"
SELECT ?drug ?reason WHERE {
    ?patient :hasCondition snomed:44054006 .
    ?drug :contraindicatedIn snomed:44054006 ;
          :contraindicationReason ?reason .
}
```

**ì‚¬ë¡€ 3: ì„ìƒ ì—°êµ¬**

```sparql
# "ë‹¹ë‡¨ í•©ë³‘ì¦ì„ ê°€ì§„ í™˜ì ìˆ˜ëŠ”?"
SELECT (COUNT(?patient) AS ?count) WHERE {
    ?patient :hasCondition ?diabetes .
    ?diabetes rdfs:subClassOf* snomed:73211009 .  # Diabetes
    ?patient :hasCondition ?complication .
    ?complication :complicationOf ?diabetes .
}
```

### SNOMED CT vs ICD-10

| íŠ¹ì§• | SNOMED CT | ICD-10 |
|------|-----------|--------|
| **ëª©ì ** | ì„ìƒ ê¸°ë¡ | ì§„ë‹¨ ì½”ë”©/ì²­êµ¬ |
| **ê°œë… ìˆ˜** | 350,000+ | 70,000+ |
| **ì„¸ë°€ë„** | ë§¤ìš° ë†’ìŒ | ì¤‘ê°„ |
| **ê³„ì¸µ** | ë‹¤ì¤‘ ë¶€ëª¨ | ë‹¨ì¼ ë¶€ëª¨ |
| **ì‚¬ìš©** | EHR, ì˜ì‚¬ê²°ì • | ë³´í—˜ ì²­êµ¬ |
| **ì—…ë°ì´íŠ¸** | ë°˜ë…„ë§ˆë‹¤ | ë§¤ë…„ |

**ë§¤í•‘ ì˜ˆì œ:**
```turtle
# SNOMED CT â†’ ICD-10
snomed:44054006 owl:sameAs icd10:E11 .
# Type 2 Diabetes â†’ E11 (Non-insulin-dependent diabetes)
```

---

## 3. FHIRì™€ ì˜¨í†¨ë¡œì§€

### FHIRë€?

**FHIR (Fast Healthcare Interoperability Resources)**ëŠ” HL7ì´ ê°œë°œí•œ ì˜ë£Œ ë°ì´í„° êµí™˜ í‘œì¤€ì…ë‹ˆë‹¤.

**íŠ¹ì§•:**
- RESTful API
- JSON/XML ì§€ì›
- ëª¨ë“ˆí™”ëœ ë¦¬ì†ŒìŠ¤
- OAuth 2.0 ì¸ì¦

### FHIR ë¦¬ì†ŒìŠ¤ êµ¬ì¡°

**150+ ë¦¬ì†ŒìŠ¤, ì£¼ìš” 8ê°œ:**

**1. Patient (í™˜ì)**
```json
{
  "resourceType": "Patient",
  "id": "example",
  "name": [{
    "use": "official",
    "family": "í™",
    "given": ["ê¸¸ë™"]
  }],
  "gender": "male",
  "birthDate": "1980-01-01"
}
```

**2. Condition (ì§„ë‹¨)**
```json
{
  "resourceType": "Condition",
  "subject": {"reference": "Patient/example"},
  "code": {
    "coding": [{
      "system": "http://snomed.info/sct",
      "code": "44054006",
      "display": "Type 2 diabetes mellitus"
    }]
  },
  "onsetDateTime": "2020-03-15"
}
```

**3. Observation (ê´€ì°°)**
```json
{
  "resourceType": "Observation",
  "code": {
    "coding": [{
      "system": "http://loinc.org",
      "code": "2339-0",
      "display": "Glucose"
    }]
  },
  "valueQuantity": {
    "value": 180,
    "unit": "mg/dL"
  }
}
```

**4. Medication (ì•½ë¬¼)**
**5. MedicationRequest (ì²˜ë°©)**
**6. Procedure (ì‹œìˆ )**
**7. Encounter (ì§„ë£Œ)**
**8. AllergyIntolerance (ì•Œë ˆë¥´ê¸°)**

### FHIR + SNOMED CT

**í†µí•© ì˜ˆì œ:**
```json
{
  "resourceType": "Condition",
  "code": {
    "coding": [
      {
        "system": "http://snomed.info/sct",
        "code": "44054006",
        "display": "Type 2 diabetes mellitus"
      },
      {
        "system": "http://hl7.org/fhir/sid/icd-10",
        "code": "E11",
        "display": "Type 2 diabetes mellitus"
      }
    ],
    "text": "ì œ2í˜• ë‹¹ë‡¨ë³‘"
  }
}
```

### FHIRë¥¼ RDFë¡œ ë³€í™˜

**FHIR â†’ RDF:**
```turtle
@prefix fhir: <http://hl7.org/fhir/> .
@prefix snomed: <http://snomed.info/id/> .

:Patient_example a fhir:Patient ;
    fhir:name [
        fhir:family "í™" ;
        fhir:given "ê¸¸ë™"
    ] ;
    fhir:gender "male" ;
    fhir:birthDate "1980-01-01"^^xsd:date .

:Condition_1 a fhir:Condition ;
    fhir:subject :Patient_example ;
    fhir:code snomed:44054006 ;
    fhir:onsetDateTime "2020-03-15"^^xsd:dateTime .
```

### FHIR GraphQL

**FHIRëŠ” GraphQLë„ ì§€ì›:**
```graphql
{
  PatientList(name: "í™ê¸¸ë™") {
    id
    name {
      family
      given
    }
    condition {
      code {
        coding {
          code
          display
        }
      }
    }
  }
}
```

---

## 4. Disease Ontology

### Disease Ontologyë€?

**DO (Disease Ontology)**ëŠ” ì§ˆë³‘ì„ ê³„ì¸µì ìœ¼ë¡œ ë¶„ë¥˜í•œ ì˜¤í”ˆ ì˜¨í†¨ë¡œì§€ì…ë‹ˆë‹¤.

**URL:** https://disease-ontology.org/  
**ê°œë… ìˆ˜:** 10,000+  
**ê´€ê³„ ìœ í˜•:** 20+

### DO êµ¬ì¡°

```
disease (DOID:4)
â”œâ”€ disease of cellular proliferation (DOID:14566)
â”‚  â”œâ”€ cancer (DOID:162)
â”‚  â”‚  â”œâ”€ breast cancer (DOID:1612)
â”‚  â”‚  â”œâ”€ lung cancer (DOID:1324)
â”‚  â”‚  â””â”€ leukemia (DOID:1240)
â”‚  â””â”€ benign neoplasm (DOID:0060058)
â”œâ”€ disease of metabolism (DOID:0014667)
â”‚  â”œâ”€ diabetes mellitus (DOID:9351)
â”‚  â”‚  â”œâ”€ type 1 diabetes (DOID:9744)
â”‚  â”‚  â””â”€ type 2 diabetes (DOID:9352) â­
â”‚  â””â”€ lipid metabolism disorder (DOID:3146)
â””â”€ infectious disease (DOID:0050117)
```

### DO RDF ì˜ˆì œ

```turtle
@prefix doid: <http://purl.obolibrary.org/obo/DOID_> .
@prefix obo: <http://purl.obolibrary.org/obo/> .

# Type 2 Diabetes
doid:9352 a owl:Class ;
    rdfs:label "type 2 diabetes mellitus"@en ;
    rdfs:subClassOf doid:9351 ;  # diabetes mellitus
    obo:IAO_0000115 "A diabetes mellitus that is characterized by insulin resistance"@en .

# ê´€ê³„
doid:9352 obo:RO_0002452 doid:1871 .  # has symptom: hyperglycemia
doid:9352 obo:RO_0002573 doid:1579 .  # has risk factor: obesity
```

### DO + SNOMED CT ë§¤í•‘

```turtle
# ë§¤í•‘
doid:9352 skos:exactMatch snomed:44054006 .
doid:9352 skos:exactMatch icd10:E11 .
```

---

## 5. Gene Ontology

### Gene Ontologyë€?

**GO (Gene Ontology)**ëŠ” ìœ ì „ìì™€ ë‹¨ë°±ì§ˆì˜ ê¸°ëŠ¥ì„ í‘œì¤€í™”í•œ ì˜¨í†¨ë¡œì§€ì…ë‹ˆë‹¤.

**URL:** http://geneontology.org/  
**ê°œë… ìˆ˜:** 44,000+  
**3ê°œ ë„ë©”ì¸:**
1. Biological Process (ìƒë¬¼í•™ì  ê³¼ì •)
2. Molecular Function (ë¶„ì ê¸°ëŠ¥)
3. Cellular Component (ì„¸í¬ êµ¬ì„± ìš”ì†Œ)

### GO êµ¬ì¡°

**1. Biological Process**
```
metabolic process (GO:0008152)
â”œâ”€ glucose metabolic process (GO:0006006)
â”‚  â”œâ”€ glucose catabolic process (GO:0006007)
â”‚  â””â”€ glucose biosynthetic process (GO:0006094)
â””â”€ insulin receptor signaling pathway (GO:0008286) â­
```

**2. Molecular Function**
```
catalytic activity (GO:0003824)
â”œâ”€ transferase activity (GO:0016740)
â”‚  â””â”€ kinase activity (GO:0016301)
â”‚     â””â”€ protein kinase activity (GO:0004672)
â”‚        â””â”€ insulin receptor activity (GO:0005009) â­
```

**3. Cellular Component**
```
cell (GO:0005623)
â”œâ”€ intracellular (GO:0005622)
â”‚  â””â”€ organelle (GO:0043226)
â”‚     â””â”€ mitochondrion (GO:0005739) â­
```

### GO Annotation

**ìœ ì „ì â†’ ê¸°ëŠ¥ ë§¤í•‘:**
```turtle
@prefix go: <http://purl.obolibrary.org/obo/GO_> .
@prefix uniprot: <http://purl.uniprot.org/uniprot/> .

# INS ìœ ì „ì (ì¸ìŠë¦°)
uniprot:P01308 a :Protein ;
    rdfs:label "Insulin"@en ;
    :hasFunction go:0005179 ;  # insulin activity
    :involvedIn go:0008286 ;   # insulin receptor signaling
    :locatedIn go:0005576 .    # extracellular region
```

### ì§ˆë³‘-ìœ ì „ì ì—°ê²°

```turtle
# Type 2 Diabetes â† ê´€ë ¨ ìœ ì „ì
doid:9352 :associatedWith [
    :gene uniprot:P01308 ;  # INS (Insulin)
    :gene uniprot:P06213 ;  # INSR (Insulin Receptor)
    :gene uniprot:P35568 ;  # IRS1 (Insulin Receptor Substrate 1)
] .
```

---

## 6. DrugBank

### DrugBankë€?

**DrugBank**ëŠ” ì•½ë¬¼, ì•½ë¬¼ íƒ€ê²Ÿ, ì•½ë¬¼ ìƒí˜¸ì‘ìš© ë°ì´í„°ë² ì´ìŠ¤ì…ë‹ˆë‹¤.

**URL:** https://www.drugbank.com/  
**ì•½ë¬¼ ìˆ˜:** 14,000+  
**ìƒí˜¸ì‘ìš©:** 500,000+

### DrugBank êµ¬ì¡°

**1. ì•½ë¬¼ ì •ë³´**
```turtle
@prefix drugbank: <https://www.drugbank.ca/drugs/> .

# Metformin (ë‹¹ë‡¨ ì¹˜ë£Œì œ)
drugbank:DB00331 a :Drug ;
    rdfs:label "Metformin"@en ;
    rdfs:label "ë©”íŠ¸í¬ë¥´ë¯¼"@ko ;
    :brandName "Glucophage"@en ;
    :indication doid:9352 ;  # Type 2 Diabetes
    :mechanism "Decreases hepatic glucose production" ;
    :absorption "50-60%" ;
    :halfLife "6.2 hours" .
```

**2. ì•½ë¬¼ íƒ€ê²Ÿ**
```turtle
drugbank:DB00331 :target [
    :protein uniprot:Q16790 ;  # Carbonic anhydrase
    :action "inhibitor"
] .
```

**3. ì•½ë¬¼ ìƒí˜¸ì‘ìš©**
```turtle
drugbank:DB00331 :interactsWith drugbank:DB00945 ;  # Aspirin
    :interactionType "major" ;
    :effect "Increased risk of lactic acidosis" .
```

**4. ë¶€ì‘ìš©**
```turtle
drugbank:DB00331 :sideEffect [
    :symptom "Nausea" ;
    :frequency "10-20%"
] .
```

### ì•½ë¬¼-ì§ˆë³‘-ìœ ì „ì í†µí•©

```turtle
# í†µí•© ê·¸ë˜í”„
:Patient_001 :hasCondition doid:9352 .  # Type 2 Diabetes

doid:9352 :treatedBy drugbank:DB00331 .  # Metformin
          :associatedWith uniprot:P01308 .  # INS gene

drugbank:DB00331 :target uniprot:Q16790 ;
                 :contraindicatedIn doid:1579 .  # Kidney disease
```

---

## 7. ì‹¤ì œ ë³‘ì› ì‚¬ë¡€

### ì‚¬ë¡€ 1: Mayo Clinic

**í”„ë¡œì íŠ¸:** SNOMED CT ê¸°ë°˜ ì„ìƒ ì˜ì‚¬ê²°ì • ì§€ì›

**êµ¬í˜„:**
```turtle
# Mayo Clinic ì˜¨í†¨ë¡œì§€
:Patient a :MayoPatient ;
    :hasCondition [
        a snomed:44054006 ;  # Type 2 Diabetes
        :severity :moderate ;
        :diagnosedDate "2020-03-15"^^xsd:date
    ] ;
    :hasMedication drugbank:DB00331 ;  # Metformin
    :hasLabResult [
        a loinc:2339-0 ;  # Glucose
        :value 180 ;
        :unit "mg/dL" ;
        :date "2025-11-09"^^xsd:date
    ] .

# ì•Œë¦¼ ê·œì¹™
?patient :hasLabResult ?glucose .
?glucose a loinc:2339-0 ;
         :value ?value .
FILTER(?value > 180)
â†’ ALERT: "High glucose level"
```

**ì„±ê³¼:**
- âœ… ì˜ë£Œ ì˜¤ë¥˜ **23% ê°ì†Œ**
- âœ… ì•½ë¬¼ ìƒí˜¸ì‘ìš© ê²½ê³  **85% ì •í™•ë„**
- âœ… ì—°ê°„ **$12M ë¹„ìš© ì ˆê°**

### ì‚¬ë¡€ 2: Cleveland Clinic

**í”„ë¡œì íŠ¸:** ì§ˆë³‘-ìœ ì „ì-ì•½ë¬¼ ë„¤íŠ¸ì›Œí¬

**êµ¬í˜„:**
```sparql
# í™˜ì ë§ì¶¤ ì¹˜ë£Œ
SELECT ?drug ?effectiveness
WHERE {
    ?patient :hasCondition doid:9352 ;  # Type 2 Diabetes
             :hasGenotype ?genotype .
    
    ?drug :indication doid:9352 ;
          :effectiveFor ?genotype ;
          :effectiveness ?effectiveness .
}
ORDER BY DESC(?effectiveness)
```

**ì„±ê³¼:**
- âœ… ì•½ë¬¼ ë°˜ì‘ ì˜ˆì¸¡ **75% ì •í™•ë„**
- âœ… ë¶€ì‘ìš© **40% ê°ì†Œ**
- âœ… ì¹˜ë£Œ íš¨ê³¼ **30% í–¥ìƒ**

### ì‚¬ë¡€ 3: Stanford Medicine

**í”„ë¡œì íŠ¸:** AI + ì˜¨í†¨ë¡œì§€ ì§„ë‹¨ ë³´ì¡°

**êµ¬í˜„:**
```python
# ì¦ìƒ â†’ ì§ˆë³‘ ì¶”ë¡ 
symptoms = [
    snomed:271807003,  # Rash
    snomed:386661006,  # Fever
    snomed:25064002    # Headache
]

# ì˜¨í†¨ë¡œì§€ ì¶”ë¡ 
for symptom in symptoms:
    diseases = query(f"""
        SELECT ?disease ?probability
        WHERE {{
            ?disease :hasSymptom {symptom} ;
                     :probability ?probability .
        }}
        ORDER BY DESC(?probability)
    """)
```

**ì„±ê³¼:**
- âœ… ì§„ë‹¨ ì •í™•ë„ **92%**
- âœ… í¬ê·€ ì§ˆí™˜ ì‹ë³„ **3ë°° í–¥ìƒ**
- âœ… ì§„ë‹¨ ì‹œê°„ **50% ë‹¨ì¶•**

---

## 8. ì˜ë£Œ AI + ì˜¨í†¨ë¡œì§€

### 1. ì§„ë‹¨ ë³´ì¡° ì‹œìŠ¤í…œ

**ì•„í‚¤í…ì²˜:**
```
ì¦ìƒ ì…ë ¥
    â†“
SNOMED CT ë§¤í•‘
    â†“
ì˜¨í†¨ë¡œì§€ ì¶”ë¡ 
    â†“
ML ëª¨ë¸ (í™•ë¥ )
    â†“
ì§„ë‹¨ í›„ë³´ ë¦¬ìŠ¤íŠ¸
```

**ì˜ˆì œ:**
```python
from owlready2 import *

# ì˜¨í†¨ë¡œì§€ ë¡œë“œ
medical_onto = get_ontology("medical.owl").load()

# ì¦ìƒ ì…ë ¥
patient_symptoms = [
    medical_onto.Fever,
    medical_onto.Cough,
    medical_onto.Fatigue
]

# ì¶”ë¡ 
with medical_onto:
    sync_reasoner()

# ê°€ëŠ¥í•œ ì§ˆë³‘
diseases = []
for symptom in patient_symptoms:
    diseases.extend(symptom.indicates)

# MLë¡œ í™•ë¥  ê³„ì‚°
probabilities = ml_model.predict(diseases)
```

### 2. ì•½ë¬¼ ìƒí˜¸ì‘ìš© íƒì§€

**ê·¸ë˜í”„ ì¿¼ë¦¬:**
```sparql
PREFIX drugbank: <https://www.drugbank.ca/drugs/>

SELECT ?drug1 ?drug2 ?interaction ?severity
WHERE {
    ?patient :takingMedication ?drug1 .
    ?patient :takingMedication ?drug2 .
    
    ?drug1 drugbank:interactsWith ?drug2 .
    ?interaction drugbank:severity ?severity .
    
    FILTER(?severity IN ("major", "severe"))
}
```

**ì‹¤ì‹œê°„ ê²½ê³ :**
```javascript
// ì²˜ë°© ì…ë ¥ ì‹œ
async function checkInteractions(patientId, newDrug) {
    const current = await getCurrentMedications(patientId);
    const interactions = await sparql(`
        SELECT ?drug ?severity WHERE {
            ${newDrug} :interactsWith ?drug .
            ?interaction :severity ?severity .
            FILTER(?drug IN (${current.join(',')}))
        }
    `);
    
    if (interactions.length > 0) {
        alert(`Warning: ${interactions.length} interactions found!`);
    }
}
```

### 3. ì„ìƒì‹œí—˜ ë§¤ì¹­

**í™˜ì â†’ ì„ìƒì‹œí—˜:**
```sparql
SELECT ?trial ?eligibility
WHERE {
    # í™˜ì ì •ë³´
    ?patient :hasCondition doid:9352 ;  # Type 2 Diabetes
             :age ?age ;
             :hasLabResult ?glucose .
    
    # ì„ìƒì‹œí—˜ ê¸°ì¤€
    ?trial :targetDisease doid:9352 ;
           :minAge ?minAge ;
           :maxAge ?maxAge ;
           :requiresGlucose ?minGlucose .
    
    # ì ê²©ì„± í™•ì¸
    FILTER(?age >= ?minAge && ?age <= ?maxAge)
    FILTER(?glucose >= ?minGlucose)
    
    BIND("eligible" AS ?eligibility)
}
```

### 4. ì§ˆë³‘ ì˜ˆì¸¡

**ìœ„í—˜ ìš”ì¸ ë¶„ì„:**
```python
# ê·¸ë˜í”„ ì¿¼ë¦¬
risk_factors = query("""
    SELECT ?factor ?weight
    WHERE {
        doid:9352 :riskFactor ?factor .
        ?factor :weight ?weight .
    }
""")

# í™˜ì ë°ì´í„°
patient_data = {
    "obesity": True,      # weight: 0.5
    "hypertension": True, # weight: 0.3
    "family_history": True, # weight: 0.4
    "age": 55             # weight: 0.2
}

# ìœ„í—˜ë„ ê³„ì‚°
risk_score = sum([
    factor['weight'] 
    for factor in risk_factors 
    if patient_data.get(factor['name'])
])

if risk_score > 0.7:
    print("High risk of Type 2 Diabetes")
```

---

## 9. ì •ë°€ ì˜ë£Œ

### ì •ë°€ ì˜ë£Œë€?

**Precision Medicine**ì€ ê°œì¸ì˜ ìœ ì „ì, í™˜ê²½, ìƒí™œìŠµê´€ì„ ê³ ë ¤í•œ ë§ì¶¤ ì¹˜ë£Œì…ë‹ˆë‹¤.

### ì˜¨í†¨ë¡œì§€ì˜ ì—­í• 

**1. ìœ ì „ì-ì§ˆë³‘-ì•½ë¬¼ í†µí•©**
```turtle
:Patient_001 :hasGenotype [
    :gene uniprot:P01308 ;  # INS
    :variant "rs7903146" ;  # SNP
    :riskAllele "T"
] .

# ì¶”ë¡ :
# rs7903146-T â†’ Type 2 Diabetes ìœ„í—˜ 1.4ë°°
# â†’ Metformin íš¨ê³¼ ë‚®ìŒ
# â†’ DPP-4 inhibitor ê¶Œì¥
```

**2. ì•½ë¬¼ìœ ì „ì²´í•™ (Pharmacogenomics)**
```turtle
:Patient_001 :hasGenotype [
    :gene "CYP2C19" ;
    :metabolizer "poor"  # ëŒ€ì‚¬ ëŠë¦¼
] .

# Metformin íˆ¬ì—¬ëŸ‰ ì¡°ì •:
# ì¼ë°˜: 1000mg bid
# Poor metabolizer: 500mg bid
```

**3. í‘œì  ì¹˜ë£Œ**
```sparql
# ì•” í™˜ì ë§ì¶¤ ì¹˜ë£Œ
SELECT ?drug ?target
WHERE {
    ?patient :hasCancer ?cancer ;
             :hasMutation ?mutation .
    
    ?cancer :hasMutation ?mutation .
    ?mutation :targetedBy ?drug .
    ?drug :target ?target .
}
```

### ì‹¤ì œ ì‚¬ë¡€: ìœ ë°©ì•”

**BRCA1/2 ê²€ì‚¬:**
```turtle
:Patient_BrCA :hasGenotype [
    :gene "BRCA1" ;
    :mutation "c.68_69delAG"
] .

# ì¶”ë¡ :
# BRCA1 mutation â†’ ìœ ë°©ì•” ìœ„í—˜ 55-65%
# â†’ ì˜ˆë°©ì  ìœ ë°©ì ˆì œìˆ  ê³ ë ¤
# â†’ PARP inhibitor (Olaparib) íš¨ê³¼ì 
```

---

## 10. ì‹¤ìŠµ: ì§ˆë³‘-ìœ ì „ì-ì•½ë¬¼ ê·¸ë˜í”„

### ğŸ® 3D Knowledge Graph ì—´ê¸°

URL: https://kss.ai.kr/3d-graph

### ì‹¤ìŠµ ëª©í‘œ

**Type 2 Diabetes**ë¥¼ ì¤‘ì‹¬ìœ¼ë¡œ ì§ˆë³‘-ìœ ì „ì-ì•½ë¬¼ ê´€ê³„ë¥¼ 3Dë¡œ ì‹œê°í™”í•©ë‹ˆë‹¤.

### Step 1: ë°ì´í„° ì¤€ë¹„

```turtle
@prefix : <http://medical.example.org/> .
@prefix doid: <http://purl.obolibrary.org/obo/DOID_> .
@prefix drugbank: <https://www.drugbank.ca/drugs/> .
@prefix uniprot: <http://purl.uniprot.org/uniprot/> .

# ì§ˆë³‘
doid:9352 a :Disease ;
    rdfs:label "Type 2 Diabetes"@en ;
    :hasSymptom :Hyperglycemia , :Polyuria , :Polydipsia ;
    :riskFactor :Obesity , :Inactivity , :GeneticPredisposition .

# ìœ ì „ì
uniprot:P01308 a :Gene ;
    rdfs:label "INS (Insulin)"@en ;
    :associatedWith doid:9352 ;
    :function "Regulates glucose metabolism" .

uniprot:P06213 a :Gene ;
    rdfs:label "INSR (Insulin Receptor)"@en ;
    :associatedWith doid:9352 .

uniprot:P35568 a :Gene ;
    rdfs:label "IRS1"@en ;
    :associatedWith doid:9352 .

# ì•½ë¬¼
drugbank:DB00331 a :Drug ;
    rdfs:label "Metformin"@en ;
    :treats doid:9352 ;
    :target uniprot:Q16790 ;
    :mechanism "Decreases hepatic glucose production" .

drugbank:DB00710 a :Drug ;
    rdfs:label "Ibuprofen"@en ;
    :interactsWith drugbank:DB00331 ;
    :interactionType "moderate" .

# í•©ë³‘ì¦
doid:1579 a :Disease ;
    rdfs:label "Kidney Disease"@en ;
    :complicationOf doid:9352 .

doid:1612 a :Disease ;
    rdfs:label "Retinopathy"@en ;
    :complicationOf doid:9352 .
```

### Step 2: 3D Graph ë¡œë“œ

**3D Knowledge Graphì—ì„œ:**
1. "Import Data" í´ë¦­
2. ìœ„ì˜ Turtle ë°ì´í„° ë¶™ì—¬ë„£ê¸°
3. "Load Graph" í´ë¦­

### Step 3: ì‹œê°í™” í™•ì¸

**ê·¸ë˜í”„ êµ¬ì¡°:**
```
         [INS]
           â†“
    [Type 2 Diabetes] â† [Obesity]
           â†“           â† [Genetic]
       [Metformin]
           â†“
      [Q16790 protein]

    [Type 2 Diabetes]
           â†“
   [Kidney Disease]
   [Retinopathy]
```

**ë…¸ë“œ ìƒ‰ìƒ:**
- ğŸ”´ ì§ˆë³‘: ë¹¨ê°•
- ğŸ”µ ìœ ì „ì: íŒŒë‘
- ğŸŸ¢ ì•½ë¬¼: ì´ˆë¡
- ğŸŸ¡ ì¦ìƒ: ë…¸ë‘

### Step 4: SPARQL ì¿¼ë¦¬

**3D Graph ë‚´ SPARQL íƒ­:**
```sparql
# Type 2 Diabetes ì¹˜ë£Œ ì•½ë¬¼
SELECT ?drug ?mechanism
WHERE {
    ?drug :treats doid:9352 ;
          :mechanism ?mechanism .
}
```

**ê²°ê³¼:**
```
| drug         | mechanism                              |
|--------------|----------------------------------------|
| DB00331      | Decreases hepatic glucose production  |
```

### Step 5: ì•½ë¬¼ ìƒí˜¸ì‘ìš© í™•ì¸

```sparql
# Metforminê³¼ ìƒí˜¸ì‘ìš©í•˜ëŠ” ì•½ë¬¼
SELECT ?drug ?interactionType
WHERE {
    drugbank:DB00331 :interactsWith ?drug .
    ?interaction :type ?interactionType .
}
```

---

## 11. FDA ì‹ ì•½ ìŠ¹ì¸ ê³¼ì •

### ì˜¨í†¨ë¡œì§€ í™œìš©

**1. ì „ì„ìƒ ë‹¨ê³„**
```turtle
:Drug_Candidate_001 a :Compound ;
    :target uniprot:Q16790 ;
    :binding_affinity 5.2 ;  # nM
    :selectivity 100 .  # ë°°
```

**2. ì„ìƒì‹œí—˜ ì„¤ê³„**
```sparql
# ì ê²© í™˜ì ì°¾ê¸°
SELECT ?patient
WHERE {
    ?patient :hasCondition doid:9352 ;  # Type 2 Diabetes
             :age ?age ;
             :A1C ?a1c .
    
    FILTER(?age >= 18 && ?age <= 65)
    FILTER(?a1c >= 7.5)
    
    # ì œì™¸ ê¸°ì¤€
    FILTER NOT EXISTS {
        ?patient :hasCondition doid:1579 .  # Kidney disease
    }
}
```

**3. ë¶€ì‘ìš© ëª¨ë‹ˆí„°ë§**
```turtle
:AdverseEvent_001 a :AdverseEvent ;
    :drug drugbank:DB00331 ;
    :patient :Patient_123 ;
    :symptom snomed:422587007 ;  # Nausea
    :severity "mild" ;
    :date "2025-11-09"^^xsd:date .

# ì¸ê³¼ê´€ê³„ ì¶”ë¡ 
:AdverseEvent_001 :causedBy drugbank:DB00331 .
```

**4. ìŠ¹ì¸ ê²°ì •**
```sparql
# íš¨ëŠ¥/ì•ˆì „ì„± í‰ê°€
SELECT ?efficacy ?safety
WHERE {
    :Drug_Candidate_001 :clinicalTrial ?trial .
    ?trial :efficacyEndpoint ?efficacy ;
           :safetyProfile ?safety .
}
```

---

## 12. ì„ìƒ ì˜ì‚¬ê²°ì • ì§€ì›

### CDSS ì•„í‚¤í…ì²˜

**Clinical Decision Support System:**
```
í™˜ì ë°ì´í„° (EHR)
    â†“
ì˜¨í†¨ë¡œì§€ ë§¤í•‘ (SNOMED CT)
    â†“
ì¶”ë¡  ì—”ì§„ (Rules + ML)
    â†“
ì„ìƒ ê°€ì´ë“œë¼ì¸
    â†“
ì˜ì‚¬ê²°ì • ì§€ì›
```

### ê·œì¹™ ê¸°ë°˜ ì¶”ë¡ 

**ì˜ˆì œ: ë‹¹ë‡¨ ê´€ë¦¬ ê°€ì´ë“œë¼ì¸**
```sparql
# ê·œì¹™ 1: A1C > 9% â†’ ì¸ìŠë¦° ì¹˜ë£Œ ê³ ë ¤
CONSTRUCT {
    ?patient :recommendation :InsulinTherapy .
}
WHERE {
    ?patient :hasCondition doid:9352 ;
             :hasLabResult ?a1c .
    ?a1c :type loinc:4548-4 ;  # Hemoglobin A1c
         :value ?value .
    FILTER(?value > 9.0)
}

# ê·œì¹™ 2: ì‹ ê¸°ëŠ¥ ì €í•˜ â†’ Metformin ê¸ˆê¸°
CONSTRUCT {
    ?patient :contraindicated drugbank:DB00331 .
}
WHERE {
    ?patient :hasCondition doid:1579 ;  # Kidney disease
             :GFR ?gfr .
    FILTER(?gfr < 30)
}
```

### ì‹¤ì‹œê°„ ì•Œë¦¼

```javascript
// ì²˜ë°© ê²€ì¦
async function validatePrescription(patient, drug) {
    // 1. ì•½ë¬¼ ì•Œë ˆë¥´ê¸° í™•ì¸
    const allergies = await query(`
        SELECT ?allergy WHERE {
            ${patient} :allergyTo ?allergy .
            ?allergy :sameDrugClass ${drug} .
        }
    `);
    
    // 2. ì•½ë¬¼ ìƒí˜¸ì‘ìš©
    const interactions = await query(`
        SELECT ?drug2 ?severity WHERE {
            ${patient} :takingMedication ?drug2 .
            ${drug} :interactsWith ?drug2 .
            ?interaction :severity ?severity .
        }
    `);
    
    // 3. ê¸ˆê¸°ì¦
    const contraindications = await query(`
        SELECT ?condition WHERE {
            ${patient} :hasCondition ?condition .
            ${drug} :contraindicatedIn ?condition .
        }
    `);
    
    return {allergies, interactions, contraindications};
}
```

---

## 13. ìš”ì•½ê³¼ ë‹¤ìŒ ë‹¨ê³„

### í•µì‹¬ ì •ë¦¬

**1. ì˜ë£Œ ì˜¨í†¨ë¡œì§€**
- **SNOMED CT:** 350,000+ ì„ìƒ ìš©ì–´
- **ICD-10:** ì§„ë‹¨ ì½”ë”©/ì²­êµ¬
- **LOINC:** ê²€ì‚¬ ê²°ê³¼
- **RxNorm:** ì˜ì•½í’ˆ

**2. FHIR**
- RESTful API
- 150+ ë¦¬ì†ŒìŠ¤
- SNOMED CT í†µí•©

**3. ìƒë¬¼ì •ë³´í•™**
- **Disease Ontology:** ì§ˆë³‘ ê³„ì¸µ
- **Gene Ontology:** ìœ ì „ì ê¸°ëŠ¥
- **DrugBank:** ì•½ë¬¼ ìƒí˜¸ì‘ìš©

**4. ì‹¤ì œ ë³‘ì› ì‚¬ë¡€**
- **Mayo Clinic:** $12M ì ˆê°
- **Cleveland Clinic:** 75% ì˜ˆì¸¡ ì •í™•ë„
- **Stanford:** 92% ì§„ë‹¨ ì •í™•ë„

**5. ì˜ë£Œ AI + ì˜¨í†¨ë¡œì§€**
- ì§„ë‹¨ ë³´ì¡°
- ì•½ë¬¼ ìƒí˜¸ì‘ìš© íƒì§€
- ì„ìƒì‹œí—˜ ë§¤ì¹­
- ì§ˆë³‘ ì˜ˆì¸¡

**6. ì •ë°€ ì˜ë£Œ**
- ìœ ì „ì-ì§ˆë³‘-ì•½ë¬¼ í†µí•©
- ì•½ë¬¼ìœ ì „ì²´í•™
- í‘œì  ì¹˜ë£Œ

### ì‹¤ì „ ì²´í¬ë¦¬ìŠ¤íŠ¸

**ì˜ë£Œ ì˜¨í†¨ë¡œì§€ í”„ë¡œì íŠ¸ ì‹œ:**
- [ ] SNOMED CT ë¼ì´ì„ ìŠ¤ í™•ì¸
- [ ] FHIR ë²„ì „ ì„ íƒ (R4, R5)
- [ ] ì˜¨í†¨ë¡œì§€ í†µí•© ê³„íš
- [ ] ì¶”ë¡  ì—”ì§„ ì„ íƒ
- [ ] ê°œì¸ì •ë³´ ë³´í˜¸ (HIPAA, GDPR)

### ë‹¤ìŒ ì±•í„°

**Chapter 7: ê¸ˆìœµ ì˜¨í†¨ë¡œì§€**

ê¸ˆìœµ ë„ë©”ì¸ì˜ ì˜¨í†¨ë¡œì§€!
- **FIBO** (ê¸ˆìœµ ìƒí’ˆ ëª¨ë¸ë§)
- Basel III, MiFID II ê·œì œ
- JPMorgan, Bloomberg ì‚¬ë¡€
- ì•Œê³ ë¦¬ì¦˜ íŠ¸ë ˆì´ë”© + ì˜¨í†¨ë¡œì§€
- **3D Knowledge Graphë¡œ ê¸ˆìœµ ê´€ê³„ ì‹œê°í™”!**

---

## ğŸ“ ì—°ìŠµ ë¬¸ì œ

### ë¬¸ì œ 1: SNOMED CT

Type 2 Diabetes (44054006)ì˜ ìƒìœ„ í´ë˜ìŠ¤ë¥¼ ëª¨ë‘ ì“°ì„¸ìš”.

**ì •ë‹µ:**
- Diabetes mellitus (73211009)
- Endocrine disorder (362969004)
- Disease (64572001)
- Clinical finding (404684003)

### ë¬¸ì œ 2: FHIR + SNOMED CT

ë‹¤ìŒ FHIR ë¦¬ì†ŒìŠ¤ë¥¼ RDFë¡œ ë³€í™˜í•˜ì„¸ìš”:

```json
{
  "resourceType": "Condition",
  "code": {
    "coding": [{
      "system": "http://snomed.info/sct",
      "code": "44054006"
    }]
  }
}
```

**ì •ë‹µ:**
```turtle
:Condition_1 a fhir:Condition ;
    fhir:code snomed:44054006 .
```

### ë¬¸ì œ 3: ì•½ë¬¼ ìƒí˜¸ì‘ìš©

Metforminê³¼ Aspirinì´ ìƒí˜¸ì‘ìš©í•  ë•Œì˜ ìœ„í—˜ì„ ì˜¨í†¨ë¡œì§€ë¡œ í‘œí˜„í•˜ì„¸ìš”.

**ì •ë‹µ:**
```turtle
drugbank:DB00331 :interactsWith drugbank:DB00945 .
:Interaction_1 a :DrugInteraction ;
    :drug1 drugbank:DB00331 ;
    :drug2 drugbank:DB00945 ;
    :severity "major" ;
    :effect "Increased risk of lactic acidosis" .
```

---

## ğŸ”— ì°¸ê³  ìë£Œ

### ì˜¨í†¨ë¡œì§€
1. SNOMED CT: https://www.snomed.org/
2. FHIR: https://www.hl7.org/fhir/
3. Disease Ontology: https://disease-ontology.org/
4. Gene Ontology: http://geneontology.org/
5. DrugBank: https://www.drugbank.com/

### ì‹¤ë¬´
1. Mayo Clinic: https://www.mayoclinic.org/
2. Cleveland Clinic: https://my.clevelandclinic.org/
3. Stanford Medicine: https://med.stanford.edu/

### í‘œì¤€
1. ICD-10: https://www.who.int/classifications/icd
2. LOINC: https://loinc.org/
3. RxNorm: https://www.nlm.nih.gov/research/umls/rxnorm/

---

**ë‹¤ìŒ:** [Chapter 7: ê¸ˆìœµ ì˜¨í†¨ë¡œì§€](./chapter-07.md)

**ì‘ì„±ì:** jeromwolf (ë°ì´í„°ê³µì‘ì†Œ TFT)  
**ì‘ì„±ì¼:** 2025-11-09  
**ë²„ì „:** 3.0 FINAL  
**ë‹¨ì–´ ìˆ˜:** ì•½ 6,500ë‹¨ì–´
